TCWP’s Mesa Laboratories MLAB Stock Holding History

TCWP’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14	Closed	-$3K	–	1154
2022 Q1	$3K	Buy	+14	New	+$3.8K	﹤0.01%	1213

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

TCWP's MLAB Position: Q2 2022 in Review

TCWP sold out of Mesa Laboratories (MLAB) in Q2 2022, closing a stake of 14 shares — an estimated $3K sold.

TCWP first reported a position in MLAB in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 175 funds tracked by Wall St. Rank hold MLAB as of Q2 2022.

TCWP reported no remaining Mesa Laboratories position as of Q2 2022 after selling out during the quarter.
TCWP sold 14 Mesa Laboratories shares in Q2 2022, an estimated $3K.
TCWP first reported a position in Mesa Laboratories in Q1 2022 and held it in 1 quarter.
TCWP's Mesa Laboratories position peaked at $3K in Q1 2022.
175 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.